Cancer programs of tomorrow will need to bring together and integrate an increasing array of disciplines, organizations, and treatment modalities to provide high-quality, cost-effective, and supportive care. This session, presented by Michael L. Blau, Chair, Health Care Venture Practice, Partner, Foley & Lardner LLP explored the business models by which various cancer care stakeholders can successfully collaborate. Examples of currently successful models for hospital–physician and hospital-hospital collaboration were discussed from a business, financial, and legal perspective.
Related Insights
May 29, 2026
Foley Viewpoints
SEC Proposes Significant Reforms to Registered Offering Framework
On May 19, 2026, the Securities and Exchange Commission (SEC) proposed sweeping amendments to its rules and forms governing registered…
May 29, 2026
Foley Corporate Governance Update
DExit One Year Later: An Assessment of SB21, the Continuing Pace of Reincorporation and the Maturation of Texas as a Corporate Domicile
When I last addressed the so-called DExit phenomenon, Delaware’s General Assembly had just enacted Senate Bill 21 in response to the growing concern that public companies, prompted by a series of decisions from the Delaware Court of Chancery, most prominently Tornetta v. Musk, were reconsidering their historical preference for incorporation in Delaware.
May 28, 2026
Foley Viewpoints
AI Transcription Tools in Health Care: What In-House Counsel Needs to Get Right
AI is changing health care faster than almost any other technology in recent memory. Among the most rapidly adopted applications are transcription tools that record encounters, convert speech to text, generate draft notes, and support scheduling, intake, triage, and other administrative workflows.